Cita APA

Akinci, B., de Freitas, M. C. F., Baker, M., Hench, R., Neidert, A., Boutros, S., . . . Oral, E. A. (2020). OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin with Leptin Receptor Agonist REGN4461. J Endocr Soc.

Chicago Style Citation

Akinci, Baris, Maria Cristina Foss de Freitas, Mark Baker, Rita Hench, Adam Neidert, Sabine Boutros, Efe Yagiz Akinci, i Elif A. Oral. "OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin With Leptin Receptor Agonist REGN4461." J Endocr Soc 2020.

Cita MLA

Akinci, Baris, et al. "OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin With Leptin Receptor Agonist REGN4461." J Endocr Soc 2020.